Michal Chovanec (M Chovanec)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Venues

Nature reviews. Urology

International journal of molecular sciences

BMC cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Indiana University Melvin and Bren Simon Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indiana University Melvin and Bren Simon Cancer Center Dec 25 2016 - Dec 25 2017

United States

research scholar :: Hematology and Oncology

Publications

Ali Amiri, Patrik Krumpolec, Michal Mego, Barbara Ukropcová, Michal Chovanec, Jozef Ukropec
Habitual physical activity modulates cardiometabolic health in long-term testicular cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (9) (2023)
Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin, Di Maria Jiang, Robert A Huddart, Daniel Y C Heng, Angelika Terbuch, Eric Winquist, Michal Chovanec, Marcus Hentrich, Christian Daniel Fankhauser, Jonathan Shamash, Xavier García Del Muro Solans, David Vaughn, Axel Heidenreich, Cora N Sternberg, Christopher Sweeney, Andrea Necchi, Carsten Bokemeyer, Mikkel Bandak, Abolghassem Jandari, Laurence Collette, Silke Gillessen, Joerg Beyer, Gedske Daugaard
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database. British journal of cancer (2023)
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, Barbora Kasperova, Michal Chovanec, Sona Ciernikova, Michal Mego
The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy. International journal of molecular sciences 23 (1) (2022)
Michal Chovanec, Nabil Adra, Mohammad Abu Zaid, Rafat Abonour, Lawrence Einhorn
High-dose chemotherapy for relapsed testicular germ cell tumours. Nature reviews. Urology (2022)
Zuzana Országhová, Katarina Kalavska, Michal Mego, Michal Chovanec
Overcoming Chemotherapy Resistance in Germ Cell Tumors. Biomedicines 10 (5) (2022)
Peter Lesko, Michal Chovanec, Michal Mego
Biomarkers of disease recurrence in stage I testicular germ cell tumours. Nature reviews. Urology 19 (11) (2022)
Michal Chovanec, Jakob Lauritsen, Mikkel Bandak, Christoph Oing, Gry Gundgaard Kier, Michael Kreiberg, Josephine Rosenvilde, Thomas Wagner, Carsten Bokemeyer, Gedske Daugaard
Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nature reviews. Urology 18 (4) (2021)
Ali Amiri, Michal Chovanec, Viktor Oliva, Milan Sedliak, Michal Mego, Jozef Ukropec, Barbara Ukropcová
Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise. Andrology 9 (6) (2021)
Katarina Kalavska, Zuzana Sestakova, Andrea Mlcakova, Katarína Kozics, Paulina Gronesova, Lenka Hurbanova, Viera Miskovska, Katarina Rejlekova, Daniela Svetlovska, Zuzana Sycova-Mila, Jana Obertova, Patrik Palacka, Jozef Mardiak, Michal Chovanec, Miroslav Chovanec, Michal Mego
Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients? International journal of molecular sciences 22 (15) (2021)
Silke Gillessen Sommer, Nicolas Sauvé, Laurence Collette, Gedske Daugaard, Ronald de Wit, Costantine Albany, Alexey A Tryakin, Karim Fizazi, Olof Stahl, Jourik A Gietema, Ugo De Giorgi, Fay H Cafferty, Aaron Richard Hansen, Torgrim Tandstad, Robert A Huddart, Andrea Necchi, Christopher J Sweeney, Xavier García Del Muro Solans, Daniel Y C Heng, Anja Lorch, Michal Chovanec, Eric Winquist, Peter S Grimison, Darren R Feldman, Angelika Terbuch, Marcus Ulrich Hentrich, Carsten Bokemeyer, Helene F S Negaard, Christian Daniel Fankhauser, Jonathan Shamash, David J Vaughn, Cora N Sternberg, Axel Heidenreich, Joerg Beyer, null null
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Joerg Beyer, Laurence Collette, Nicolas Sauvé, Gedske Daugaard, Darren R Feldman, Torgrim Tandstad, Alexey A Tryakin, Olof Stahl, Enrique Gonzalez-Billalabeitia, Ugo De Giorgi, Stephane Culine, Ronald de Wit, Aaron Richard Hansen, Marko Bebek, Angelika Terbuch, Costantine Albany, Marcus Hentrich, Jourik A Gietema, Helene F S Negaard, Robert A Huddart, Anja Lorch, Fay H Cafferty, Daniel Y C Heng, Christopher J Sweeney, Eric Winquist, Michal Chovanec, Christian Daniel Fankhauser, Daniel Stark, Peter S Grimison, Andrea Necchi, Ben Tran, Axel Heidenreich, Jonathan Shamash, Cora N Sternberg, David J Vaughn, Ignacio Duran, Carsten Bokemeyer, Anna Patrikidou, Richard Cathomas, Samson Assele, Silke Gillessen Sommer, null null
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Silvia Schmidtova, Katarina Kalavska, Veronika Liskova, Jana Plava, Svetlana Miklikova, Lucia Kucerova, Miroslava Matuskova, Lucia Rojikova, Zuzana Cierna, Adriana Rogozea, Heiko Konig, Costantine Albany, Michal Mego, Michal Chovanec
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines. International journal of molecular sciences 22 (8) (2021)
Michal Chovanec, L Vasilkova, L Petrikova, J Obertova, P Palacka, K Rejlekova, Z Sycova-Mila, K Kalavska, D Svetlovska, B Mladosievicova, J Mardiak, M Mego
Long-term sexual functioning in germ-cell tumor survivors. BMC cancer 20 (1) (2020)
Michal Chovanec, J Mardiak, M Mego
Immune mechanisms and possible immune therapy in testicular germ cell tumours. Andrology 7 (4) (2019)
Michal Chovanec, Fadi Taza, Maitri Kalra, Noah Hahn, Kenneth P Nephew, Michael J Spinella, Costantine Albany
Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review. Targeted oncology 13 (1) (2019)
Michal Chovanec, Lucia Vasilkova, Lucia Setteyova, Jana Obertova, Patrik Palacka, Katarina Rejlekova, Zuzana Sycova-Mila, Katarina Kalavska, Daniela Svetlovska, Silvia Cingelova, Beata Mladosievicova, Jozef Mardiak, Michal Mego
Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors. The oncologist 23 (5) (2018)
Michal Chovanec, Zuzana Cierna, Viera Miskovska, Katarina Machalekova, Katarina Kalavska, Katarina Rejlekova, Daniela Svetlovska, Dusan Macak, Stanislav Spanik, Karol Kajo, Pavel Babal, Michal Mego, Jozef Mardiak
βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors. BMC cancer 18 (1) (2018)
Michal Chovanec, Ugo De Giorgi, Michal Mego
Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors. Advances in urology 2018 (2018)

Michal Chovanec.css-eqlu8i{font-size:small;padding-left:4px;} (M Chovanec)

Publication Activity (10 Years)

Top Topics

Top Venues

Michal Chovanec (M Chovanec)